MEIP Stock Price | MEI Pharma Inc P/E, Revenue, EPS, & Forecasts

MEI Pharma Inc • MEIP

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About MEI Pharma Inc

Ticker

MEIP

Trading on

NASDAQ

ISIN

US55279B2025

Industry

Biotechnology

Sector

Healthcare

CEO

Headquarters

9920 Pacific Heights Blvd., San Diego, CA, United States, 92121

Employees

Website

https://meipharma.com

MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.

Metrics

BasicAdvanced

Market cap

$101M

P/E ratio

EPS

-$4.75

Dividend Yield

0.00%

Beta

0.22

Forward P/E ratio

EBIDTA

$-16.6M

Ex dividend date

2023-11-16

Price & volume

Market cap

$101M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

20.6

Trailing P/E

Price to sales

0.27

Price to book

5.64

Earnings

EPS

-$4.75

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-16.6M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

0.22

52-week High

$8.25

52-week Low

$1.46

50-day moving average

$4.56

200-day moving average

$2.94

Short ratio

5.23

Short %

8.34%

Management effectiveness

ROE (TTM)

-89.74%

ROA (TTM)

-23.23%

Profit margin

0.00%

Gross profit margin

$-5.6M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

-100.00%

Share stats

Outstanding Shares

32.8M

Float

5.7M

Insiders %

14.45%

Institutions %

8.13%

Analyst Insights & forecasts

0% Buy

100% Hold

0% Sell

Based on information from 1 analysts.

Average price target

$20.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$105.30

Q4 • 03Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-2.6M

-∞%

Q1 • 25

$0M

$-2.7M

-∞%

Q2 • 25

NaN%

4.47%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$20.8M

$1.2M

5.96%

Q1 • 25

$18.3M

$1.4M

7.40%

Q2 • 25

-12.00%

9.37%

24.29%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-3.3M

$0M

$-3.3M

Q1 • 25

$-2.5M

$0M

$-2.5M

Q2 • 25

-24.67%

NaN%

-24.67%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a MEI Pharma Inc share?

MEI Pharma Inc shares are currently traded for undefined per share.

How many shares does MEI Pharma Inc have?

MEI Pharma Inc currently has 32.8M shares.

Does MEI Pharma Inc pay dividends?

No, MEI Pharma Inc doesn't pay dividends.

What is MEI Pharma Inc 52 week high?

MEI Pharma Inc 52 week high is $8.25.

What is MEI Pharma Inc 52 week low?

MEI Pharma Inc 52 week low is $1.46.

What is the 200-day moving average of MEI Pharma Inc?

MEI Pharma Inc 200-day moving average is $2.94.

Who is MEI Pharma Inc CEO?

The CEO of MEI Pharma Inc is -.

How many employees MEI Pharma Inc has?

MEI Pharma Inc has 28 employees.

What is the market cap of MEI Pharma Inc?

The market cap of MEI Pharma Inc is $101M.

What is the P/E of MEI Pharma Inc?

The current P/E of MEI Pharma Inc is null.

What is the EPS of MEI Pharma Inc?

The EPS of MEI Pharma Inc is -$4.75.

What is the PEG Ratio of MEI Pharma Inc?

The PEG Ratio of MEI Pharma Inc is 20.6.

What do analysts say about MEI Pharma Inc?

According to the analysts MEI Pharma Inc is considered a hold.